The Company of Biologists renews Read & Publish agreement with EIFL for a further three years

Under this agreement, corresponding authors based in 33 developing and transition economy countries will continue to be able to publish an unlimited number of Open Access research articles without paying article processing charges (APCs). This applies to the Company’s two fully Open Access journals – Disease Models & Mechanisms and Biology Open – as well as our hybrid journals, Development, Journal of Cell Science and Journal of Experimental Biology. Researchers at participating institutions will also retain unlimited access to these journals and their archives, which date back to 1853.

Eligible countries

Albania, Armenia, Azerbaijan, Congo, Côte d’Ivoire, Ethiopia, Fiji, Georgia, Ghana, Kenya, Kosovo, Kyrgyzstan, Laos, Latvia, Lesotho, Lithuania, Malawi, Maldives, Moldova, Myanmar, Namibia, Nepal, North Macedonia, Palestine, Senegal, Serbia, Sudan, Tanzania, Uganda, Ukraine, Uzbekistan, Zambia, Zimbabwe.

Read the full announcement here.